Reports from APACC 2017

 APACC 2017 Logo

Clinical Blog Posts from ASHM Scholarship recipients at the Asia Pacific Conference on AIDS & Co-infections 2017

APACC 2017  I  1 - 3 June 2017  I  Hong kong

Subscribe to the Blog:

Your Name:
Your Email:





dr-ken-koh-2 Kenneth Koh
General Practitioner
Kym Collins Kym Collins
Samuel Elliott Samuel Elliott
 Clancy Barrett Clancy Barrett
Sexual Health Nurse
Mark Rowe

Mark Rowe
Clinical Nurse Specialist





APACC 2017—Who attended

At the close of the 2nd Asia Pacific AIDS & Co-infections Conference (APACC) that took place from 1 to 3 June 2017 in Hong Kong, faculty memb

New HIV drugs/regimens

At one particular session of the 2nd Asia Pacific AIDS & Co-infections Conference (APACC) that took place from 1 to 3 June 2

Population-based PrEP implementation in New South Wales, Australia

This session was delivered by Dr. Andrew Grulich (Kirby Institute, Australia). Dr. Grulich began by stating that, 'We know PrEP works'. He presented

Hep B New Agents

A very brief blog on Hep B treatment and new agents presented by Jürgen Rockstroh TAF works for Hep B Here's the data Can we cure Hep B like He

Adolescents and HIV

These are some stand out points from the  presentations at APACC covering issues related to HIV +ve youth. #1 cause of death in 18-25 age group

APACC conference mood

It is Saturday evening and the conference is over.  I have been sitting and reflecting on the experience of the last few days.  Our global p

A blog in pictures

A picture paints a thousand words - Dual Drug Therapy.. a blog in pictures (a Plog?) This is the history of therapies in HIV 3 drugs work, why are

My impressions of the first 24 hours of APACC 2017

Day 1 of APACC 2017 Other bloggers have written eloquently on sessions on day 1 at this meeting so I thought I might report on my impressions on the

APACC Highlights

As the 2nd Asia Pacific AIDS & Co-infections Conference (APACC) draws to a close I am reinvigorated and ready to implement changes in my

PrEP in Asia

The efficacy of the HIV medication Truvada as an HIV prophylaxis is very well established in the sexual health and HIV treatment/prevention world. Tru

Using ICT to reach key populations

Recruiting people into HIV services Panus Na Nakorn The breakout session PA_9 was entitled, 'Innovative HIV testing, prevention and care service deli

The ageing of PLWHIV calls for new models of primary care.

Rajasthan, R, Malaysia ; HIV and ageing Study.   One of the emerging challenges is the ageing cohort of PLWHIV within Australia. Many of these

Managing HIV / HepC; Sofosbuvir / Velpatasvir effective with management well suited to primary care settings.

      Doyle,J (session presentation) ; coEC Study Lu,Y (2 poster presentations) ; ASTRAL-5 Study This presentation by J Doyle from

Asia-Pacific HIV Clinical Forum: Integrase inhibitors

HIV Forum—31 May 2017 (11am to 6pm) I would like to present my interpretation of a session at the HIV Clinical Forum (for integrate inhibitors) held

Asia-specific barriers to care

This area was addressed by two speakers, these being Fujie Zhang and Martin Choo. Dr. Zhang is a medical practitioner whilst Mr. Choo is a social scie

APACC 2017—Key note lecture

Where is the epidemic heading? Chris Beyrer opened the conference with his keynote lecture entitled, HIV/AIDS in the Asia Pacific: Where is the epide


Twitter response: "Could not authenticate you."